NICE guidelines on the management of diabetes in pregnancy indicate that rtCGM should be considered in pregnant women with insulin-treated type 2 diabetes if they have problematic severe hypoglycaemia or unstable blood glucose levels causing concern despite efforts to optimise plasma glucose [89]. The gene discussed is INS; the disease is type 2 diabetes mellitus.